Guardant Health (GH) PT Lowered to $80 at Goldman Sachs
Tweet
Share
E-mailGet Alerts GH Hot Sheet
Price: $163.06 -0.82%
Rating Summary:
28 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
28 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Goldman Sachs analyst Matthew Sykes lowered the price target on Guardant Health (NASDAQ: GH) to $80.00 (from $90.00) while maintaining a Buy rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- Dell (DELL) PT Raised to $500; TD Cowen: 'Phenomenal Results & Guidance'
- Palo Alto Networks (PANW) PT Raised to $420 at DA Davidson on Strong Q4 Upside
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
